Replies to post #1480 on Can Fite BioPharma Ltd (CANF)

[JoeWo]

End of July coming in 11 calendar days from today.

----------------

Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance, Plans to File IND Shortly

Source: Business Wire
Piclidenoson to be evaluated for the treatment of COVID-19 infected patients with moderate symptoms
Can-Fite BioPharma Ltd. (NYSE American:CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced today that it has amended its Phase II COVID-19 study protocol based on inputs from the U.S. Food and Drug Administration (FDA) and its Pre-Investigational New Drug (IND) fling. The Company plans to file an IND application with its completed protocol before the end of July.

[midastouch017]

In addition to using its assay in the development of its own cannabis derived compound-based therapeutics, Can-Fite plans to market the assay on a ‘fee for service’ basis to researchers and other cannabis companies worldwide.

Some extra cash $$$ for CANF is always welcome.

:-)